Cerus

CERS · NASDAQ

$2.31+$0.09 (+4.05%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $2.22

Latest news

Press releaseOct 19, 4:01 PM ETBusiness Wire
Cerus Corporation to Release Third Quarter 2026 Financial Results on November 2, 2026
Press releaseOct 14, 4:30 PM ETBusiness Wire
Cerus Corporation Announces Workshop and Abstracts at the 2026 AABB Annual Meeting
NewsJul 31, 8:03 AM ETAvi Kapoor
Apple, Stryker, Coinbase And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
NewsJul 30, 5:05 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
Press releaseJul 30, 4:01 PM ETBusiness Wire
Cerus Corporation Announces Second Quarter 2026 Financial Results
Press releaseJul 16, 4:01 PM ETBusiness Wire
Cerus Corporation to Release Second Quarter 2026 Financial Results on July 30, 2026
Press releaseJun 17, 8:30 AM ETBusiness Wire
Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress
NewsJun 10, 10:43 PM ETShivdeep Dhaliwal
Cathie Wood Sells Robinhood Stock, Doubles Down On This George Soros-Backed AI Stock
Press releaseJun 8, 8:30 AM ETBusiness Wire
Cerus Corporation Closes New Debt Facility of Up to $110 Million
Press releaseMay 27, 11:35 AM ETBusiness Wire
Bradley L. Radoff Announces Intent to Withhold Votes from Chair and CEO William Greenman and Director Ann Lucena
NewsMay 20, 8:48 AM ETAvi Kapoor
Top 2 Health Care Stocks That May Plunge This Month
NewsMay 1, 8:05 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
NewsApr 30, 5:31 PM ET
Cerus Q1 2026 Earnings Call Transcript
NewsApr 30, 5:06 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
Press releaseApr 30, 4:01 PM ETBusiness Wire
Cerus Corporation Announces First Quarter 2026 Financial Results
NewsApr 30, 7:11 AM ET
Earnings Scheduled For April 30, 2026
Press releaseApr 27, 8:00 AM ETBusiness Wire
Cerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System
Press releaseApr 16, 4:01 PM ETBusiness Wire
Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026
Press releaseMar 16, 4:05 PM ETBusiness Wire
Cerus Appoints Vivek Jayaraman as President and Chief Executive Officer
NewsMar 3, 8:04 AM ETAvi Kapoor
MongoDB, Surgery Partners, Harrow And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
NewsMar 2, 4:06 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
NewsMar 2, 4:04 PM ET
Cerus Q4 Earnings Assessment
Press releaseMar 2, 4:01 PM ETBusiness Wire
Cerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results
NewsFeb 27, 12:02 PM ET
Earnings Preview For Cerus
Press releaseFeb 20, 8:30 AM ETBusiness Wire
Cerus Corporation to Participate in the TD Cowen 46th Annual Health Care Conference
Press releaseFeb 17, 4:01 PM ETBusiness Wire
Cerus Corporation to Release Fourth Quarter and Full-Year 2025 Financial Results on March 2, 2026
Press releaseJan 22, 7:30 AM ETBusiness Wire
DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus' INTERCEPT™ Blood System in Routine Clinical Practice
Press releaseJan 11, 4:00 PM ETBusiness Wire
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook
Press releaseDec 10, 4:15 PM ETBusiness Wire
Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of America
NewsNov 6, 4:06 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
Press releaseNov 6, 4:01 PM ETBusiness Wire
Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance
NewsNov 6, 6:12 AM ET
Earnings Scheduled For November 6, 2025
Press releaseOct 21, 8:30 AM ETBusiness Wire
Cerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting
Press releaseOct 16, 4:00 PM ETBusiness Wire
Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025
Press releaseAug 25, 9:00 AM ETBusiness Wire
The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions
Press releaseAug 21, 8:30 AM ETBusiness Wire
Cerus Corporation to Participate in the Cantor Global Healthcare Conference 2025

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Cerus Corporation to Release Third Quarter 2026 Financial Results on November 2, 2026

Cerus Corporation Announces Workshop and Abstracts at the 2026 AABB Annual Meeting

Apple, Stryker, Coinbase And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

Cerus Corporation Announces Second Quarter 2026 Financial Results

Cerus Corporation to Release Second Quarter 2026 Financial Results on July 30, 2026

Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress

Cathie Wood Sells Robinhood Stock, Doubles Down On This George Soros-Backed AI Stock

Cerus Corporation Closes New Debt Facility of Up to $110 Million

Bradley L. Radoff Announces Intent to Withhold Votes from Chair and CEO William Greenman and Director Ann Lucena

Top 2 Health Care Stocks That May Plunge This Month

12 Health Care Stocks Moving In Friday's Pre-Market Session

Cerus Q1 2026 Earnings Call Transcript

12 Health Care Stocks Moving In Thursday's After-Market Session

Cerus Corporation Announces First Quarter 2026 Financial Results

Earnings Scheduled For April 30, 2026

Cerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System

Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026

Cerus Appoints Vivek Jayaraman as President and Chief Executive Officer

MongoDB, Surgery Partners, Harrow And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

12 Health Care Stocks Moving In Monday's After-Market Session

Cerus Q4 Earnings Assessment

Cerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results

Earnings Preview For Cerus

Cerus Corporation to Participate in the TD Cowen 46th Annual Health Care Conference

Cerus Corporation to Release Fourth Quarter and Full-Year 2025 Financial Results on March 2, 2026

DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus' INTERCEPT™ Blood System in Routine Clinical Practice

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook

Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of America

12 Health Care Stocks Moving In Thursday's After-Market Session

Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance

Earnings Scheduled For November 6, 2025

Cerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting

Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025

The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions

Cerus Corporation to Participate in the Cantor Global Healthcare Conference 2025